Despite the fact that several biomarkers (PD-L1 expression, tumor-infiltrating lymphocytes, mutational burden, immune gene signatures and microsatellite instability) have been proposed, their sensibility and sensitivity are limited (69). This evidence concerns the gene CD274 and neoplasm.